HEADER TRANSFERASE 21-NOV-13 4CG8 TITLE HUMAN CHOLINE KINASE A1 IN COMPLEX WITH COMPOUND 14 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CHOLINE KINASE ALPHA; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 75-457; COMPND 5 SYNONYM: CHOLINE KINASE A1, CK, CHETK-ALPHA, ETHANOLAMINE KINASE, EK; COMPND 6 EC: 2.7.1.32, 2.7.1.82; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VARIANT: STAR; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PMALC2X KEYWDS TRANSFERASE, DRUG TARGET, CANCER EXPDTA X-RAY DIFFRACTION AUTHOR B.RUBIO-RUIZ,A.FIGUEROLA-CONCHAS,A.ENTRENA-GUADIX,R.HURTADO-GUERRERO, AUTHOR 2 A.CONEJO-GARCIA REVDAT 3 20-DEC-23 4CG8 1 REMARK REVDAT 2 05-FEB-14 4CG8 1 JRNL REVDAT 1 15-JAN-14 4CG8 0 JRNL AUTH B.RUBIO-RUIZ,A.FIGUEROLA-CONCHAS,J.RAMOS-TORRECILLAS, JRNL AUTH 2 F.CAPITAN-CANADAS,P.RIOS-MARCO,M.P.CARRASCO,M.A.GALLO, JRNL AUTH 3 A.ESPINOSA,C.MARCO,C.CONCEPCION,A.ENTRENA-GUADIX, JRNL AUTH 4 R.HURTADO-GUERRERO,A.CONEJO-GARCIA JRNL TITL DISCOVERY OF A NEW BINDING SITE ON HUMAN CHOLINE KINASE A1: JRNL TITL 2 DESIGN, SYNTHESIS, CRYSTALLOGRAPHIC STUDIES AND BIOLOGICAL JRNL TITL 3 EVALUATION OF ASYMMETRICAL BISPYRIDINIUM DERIVATIVES JRNL REF J.MED.CHEM. V. 57 507 2014 JRNL REFN ISSN 0022-2623 JRNL PMID 24387243 JRNL DOI 10.1021/JM401665X REMARK 2 REMARK 2 RESOLUTION. 1.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0117 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 42775 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.203 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1258 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.75 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.80 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2761 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.93 REMARK 3 BIN R VALUE (WORKING SET) : 0.2430 REMARK 3 BIN FREE R VALUE SET COUNT : 88 REMARK 3 BIN FREE R VALUE : 0.2820 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2935 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 310 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.19 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.42000 REMARK 3 B22 (A**2) : 0.42000 REMARK 3 B33 (A**2) : -0.85000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.120 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.110 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.073 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.422 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.948 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.941 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3101 ; 0.009 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4181 ; 1.291 ; 1.989 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 361 ; 5.103 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 153 ;31.471 ;23.399 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 562 ;13.919 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 23 ;20.290 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 424 ; 0.093 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2385 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 80 A 457 REMARK 3 ORIGIN FOR THE GROUP (A): 17.0397 -17.4182 6.5482 REMARK 3 T TENSOR REMARK 3 T11: 0.0534 T22: 0.0377 REMARK 3 T33: 0.0333 T12: -0.0077 REMARK 3 T13: 0.0066 T23: 0.0283 REMARK 3 L TENSOR REMARK 3 L11: 0.0808 L22: 0.2161 REMARK 3 L33: 0.3182 L12: -0.0987 REMARK 3 L13: -0.0630 L23: 0.1637 REMARK 3 S TENSOR REMARK 3 S11: -0.0112 S12: 0.0248 S13: 0.0176 REMARK 3 S21: 0.0478 S22: 0.0200 S23: 0.0198 REMARK 3 S31: 0.0121 S32: 0.0199 S33: -0.0088 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 4CG8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 21-NOV-13. REMARK 100 THE DEPOSITION ID IS D_1290059046. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 73 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.92 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 44130 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 15.10 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 22.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.84 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 15.50 REMARK 200 R MERGE FOR SHELL (I) : 0.60000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 6.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 3G15 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 110.55650 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 30.77700 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 30.77700 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 165.83475 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 30.77700 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 30.77700 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 55.27825 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 30.77700 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 30.77700 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 165.83475 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 30.77700 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 30.77700 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 55.27825 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 110.55650 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2280 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 34150 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 61.55400 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 -61.55400 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 75 REMARK 465 GLN A 76 REMARK 465 PRO A 77 REMARK 465 PRO A 78 REMARK 465 ALA A 79 REMARK 465 ALA A 150 REMARK 465 ILE A 151 REMARK 465 LEU A 152 REMARK 465 GLN A 153 REMARK 465 MET A 154 REMARK 465 ARG A 155 REMARK 465 SER A 156 REMARK 465 CYS A 157 REMARK 465 ASN A 158 REMARK 465 LYS A 159 REMARK 465 GLU A 160 REMARK 465 GLY A 161 REMARK 465 SER A 162 REMARK 465 GLU A 163 REMARK 465 GLN A 164 REMARK 465 ALA A 165 REMARK 465 GLN A 166 REMARK 465 LYS A 167 REMARK 465 GLU A 168 REMARK 465 ASN A 169 REMARK 465 GLU A 170 REMARK 465 PHE A 171 REMARK 465 GLN A 172 REMARK 465 GLY A 173 REMARK 465 ALA A 174 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TYR A 359 OH REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 318 NE - CZ - NH2 ANGL. DEV. = -3.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 211 172.08 179.33 REMARK 500 PRO A 241 41.72 -81.97 REMARK 500 ASN A 281 78.73 64.15 REMARK 500 SER A 298 119.11 -161.13 REMARK 500 ASP A 306 46.21 -153.86 REMARK 500 ASP A 330 62.91 64.37 REMARK 500 PHE A 435 149.66 -171.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE G8S A 1458 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE G8V A 1459 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4CG9 RELATED DB: PDB REMARK 900 HUMAN CHOLINE KINASE A1 IN COMPLEX WITH COMPOUND 12 REMARK 900 RELATED ID: 4CGA RELATED DB: PDB REMARK 900 HUMAN CHOLINE KINASE A1 IN COMPLEX WITH COMPOUND 5 DBREF 4CG8 A 75 457 UNP P35790 CHKA_HUMAN 75 457 SEQRES 1 A 383 PRO GLN PRO PRO ALA ASP GLU GLN PRO GLU PRO ARG THR SEQRES 2 A 383 ARG ARG ARG ALA TYR LEU TRP CYS LYS GLU PHE LEU PRO SEQRES 3 A 383 GLY ALA TRP ARG GLY LEU ARG GLU ASP GLU PHE HIS ILE SEQRES 4 A 383 SER VAL ILE ARG GLY GLY LEU SER ASN MET LEU PHE GLN SEQRES 5 A 383 CYS SER LEU PRO ASP THR THR ALA THR LEU GLY ASP GLU SEQRES 6 A 383 PRO ARG LYS VAL LEU LEU ARG LEU TYR GLY ALA ILE LEU SEQRES 7 A 383 GLN MET ARG SER CYS ASN LYS GLU GLY SER GLU GLN ALA SEQRES 8 A 383 GLN LYS GLU ASN GLU PHE GLN GLY ALA GLU ALA MET VAL SEQRES 9 A 383 LEU GLU SER VAL MET PHE ALA ILE LEU ALA GLU ARG SER SEQRES 10 A 383 LEU GLY PRO LYS LEU TYR GLY ILE PHE PRO GLN GLY ARG SEQRES 11 A 383 LEU GLU GLN PHE ILE PRO SER ARG ARG LEU ASP THR GLU SEQRES 12 A 383 GLU LEU SER LEU PRO ASP ILE SER ALA GLU ILE ALA GLU SEQRES 13 A 383 LYS MET ALA THR PHE HIS GLY MET LYS MET PRO PHE ASN SEQRES 14 A 383 LYS GLU PRO LYS TRP LEU PHE GLY THR MET GLU LYS TYR SEQRES 15 A 383 LEU LYS GLU VAL LEU ARG ILE LYS PHE THR GLU GLU SER SEQRES 16 A 383 ARG ILE LYS LYS LEU HIS LYS LEU LEU SER TYR ASN LEU SEQRES 17 A 383 PRO LEU GLU LEU GLU ASN LEU ARG SER LEU LEU GLU SER SEQRES 18 A 383 THR PRO SER PRO VAL VAL PHE CYS HIS ASN ASP CYS GLN SEQRES 19 A 383 GLU GLY ASN ILE LEU LEU LEU GLU GLY ARG GLU ASN SER SEQRES 20 A 383 GLU LYS GLN LYS LEU MET LEU ILE ASP PHE GLU TYR SER SEQRES 21 A 383 SER TYR ASN TYR ARG GLY PHE ASP ILE GLY ASN HIS PHE SEQRES 22 A 383 CYS GLU TRP MET TYR ASP TYR SER TYR GLU LYS TYR PRO SEQRES 23 A 383 PHE PHE ARG ALA ASN ILE ARG LYS TYR PRO THR LYS LYS SEQRES 24 A 383 GLN GLN LEU HIS PHE ILE SER SER TYR LEU PRO ALA PHE SEQRES 25 A 383 GLN ASN ASP PHE GLU ASN LEU SER THR GLU GLU LYS SER SEQRES 26 A 383 ILE ILE LYS GLU GLU MET LEU LEU GLU VAL ASN ARG PHE SEQRES 27 A 383 ALA LEU ALA SER HIS PHE LEU TRP GLY LEU TRP SER ILE SEQRES 28 A 383 VAL GLN ALA LYS ILE SER SER ILE GLU PHE GLY TYR MET SEQRES 29 A 383 ASP TYR ALA GLN ALA ARG PHE ASP ALA TYR PHE HIS GLN SEQRES 30 A 383 LYS ARG LYS LEU GLY VAL HET G8S A1458 42 HET G8V A1459 16 HETNAM G8S 4-[(4-CHLOROPHENYL)(METHYL)AMINO]-1-{4-[4-(4-{[4- HETNAM 2 G8S (DIMETHYLAMINO)PYRIDINIUM-1-YL]METHYL}PHENYL) HETNAM 3 G8S BUTYL]BENZYL}PYRIDINIUM HETNAM G8V 1-BENZYL-4-(DIMETHYLAMINO)PYRIDINIUM FORMUL 2 G8S C37 H41 CL N4 2+ FORMUL 3 G8V C14 H17 N2 1+ FORMUL 4 HOH *310(H2 O) HELIX 1 1 GLU A 84 LEU A 99 1 16 HELIX 2 2 PRO A 100 ARG A 104 5 5 HELIX 3 3 ARG A 107 PHE A 111 5 5 HELIX 4 4 GLU A 175 ARG A 190 1 16 HELIX 5 5 ASP A 215 SER A 220 5 6 HELIX 6 6 LEU A 221 GLY A 237 1 17 HELIX 7 7 LYS A 247 LEU A 261 1 15 HELIX 8 8 GLU A 267 SER A 279 1 13 HELIX 9 9 ASN A 281 SER A 295 1 15 HELIX 10 10 GLN A 308 GLY A 310 5 3 HELIX 11 11 ARG A 339 TRP A 350 1 12 HELIX 12 12 ILE A 366 TYR A 369 5 4 HELIX 13 13 THR A 371 GLN A 387 1 17 HELIX 14 14 ASP A 389 LEU A 393 5 5 HELIX 15 15 SER A 394 SER A 431 1 38 HELIX 16 16 GLY A 436 GLY A 456 1 21 SHEET 1 AA 5 HIS A 112 ARG A 117 0 SHEET 2 AA 5 MET A 123 SER A 128 -1 O LEU A 124 N ILE A 116 SHEET 3 AA 5 LYS A 142 LEU A 147 -1 O VAL A 143 N CYS A 127 SHEET 4 AA 5 GLY A 203 GLN A 207 -1 O ARG A 204 N ARG A 146 SHEET 5 AA 5 LEU A 196 PHE A 200 -1 N TYR A 197 O LEU A 205 SHEET 1 AB 3 SER A 211 ARG A 213 0 SHEET 2 AB 3 ILE A 312 LEU A 315 -1 O LEU A 314 N ARG A 212 SHEET 3 AB 3 LEU A 326 LEU A 328 -1 O MET A 327 N LEU A 313 SHEET 1 AC 2 VAL A 300 CYS A 303 0 SHEET 2 AC 2 SER A 335 TYR A 338 -1 O SER A 335 N CYS A 303 SHEET 1 AD 2 TYR A 352 ASP A 353 0 SHEET 2 AD 2 ARG A 363 ALA A 364 -1 O ARG A 363 N ASP A 353 CISPEP 1 TYR A 359 PRO A 360 0 7.14 SITE 1 AC1 12 THR A 252 TYR A 256 ASN A 305 ASP A 306 SITE 2 AC1 12 GLN A 308 TYR A 333 TYR A 354 LEU A 419 SITE 3 AC1 12 TRP A 420 TRP A 423 ILE A 433 TYR A 440 SITE 1 AC2 6 ARG A 270 ARG A 318 GLN A 324 ALA A 428 SITE 2 AC2 6 SER A 431 PHE A 435 CRYST1 61.554 61.554 221.113 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016246 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016246 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004523 0.00000